切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2021, Vol. 15 ›› Issue (03) : 174 -176. doi: 10.3877/cma.j.issn.1674-0807.2021.03.008

综述

触诊阴性乳腺癌定位的研究进展
刘奋德1, 王虎霞2, 王星光1, 赵静2, 宋张骏3,()   
  1. 1. 710021 西安医学院研究生工作部
    2. 710061 西安,陕西省肿瘤医院乳腺科
    3. 710068 西安,陕西省人民医院肿瘤外科
  • 收稿日期:2020-08-01 出版日期:2021-07-01
  • 通信作者: 宋张骏
  • 基金资助:
    陕西省科技计划项目(2018SF-233); 陕西省卫生健康科研基金项目(2018D029); 西安市科技计划项目(2019115213YX007SF040(3))

Research progress on location of nonpalpable breast cancer

Fende Liu1, Huxia Wang2, Xingguang Wang1   

  • Received:2020-08-01 Published:2021-07-01
引用本文:

刘奋德, 王虎霞, 王星光, 赵静, 宋张骏. 触诊阴性乳腺癌定位的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2021, 15(03): 174-176.

Fende Liu, Huxia Wang, Xingguang Wang. Research progress on location of nonpalpable breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2021, 15(03): 174-176.

随着乳腺癌筛查技术的提高,越来越多不同类型的乳腺癌被发现。在临床上有一类触诊阴性乳腺癌,由于病变早期体积较小或者位置较深,很难通过触诊发现。对于触诊阴性乳腺癌患者,手术成功的关键在于对病灶的精确定位。导丝定位是触诊阴性乳腺癌手术定位的标准方法,在临床广泛使用,但由于其自身的局限性,也出现了很多替代方法。目前,触诊阴性乳腺癌的定位方法也在不断探索中,笔者前期在触诊阴性乳腺癌检查方面做了大量研究,通过回顾目前用于触诊阴性乳腺癌病变的定位方法,发现选择合适的定位方法是触诊阴性乳腺癌患者治疗需要解决的问题。

[1]
Schermers B, Van dH, Loo CE, et al. Feasibility of magnetic marker localisation for non-palpable breast cancer[J]. Breast,2017,33:50-56.
[2]
史立晖,李智,张腾,等. 钼靶X线导丝定位切除触诊阴性乳腺病灶的临床应用价值[J]. 中国普外基础与临床杂志,2014,21(10):1299-1301.
[3]
Price ER, Khoury AL, Esserman LJ, et al. Initial clinical experience with an inducible magnetic seed system for preoperative breast lesion localization[J]. AJR Am J Roentgenol,2018,210(4):913-917.
[4]
Dinome ML, Kusske AM, Attai DJ, et al. Microchipping the breast: an effective new technology for localizing non-palpable breast lesions for surgery[J]. Breast Cancer Res Treat, 2019,175(1):165-170.
[5]
Frank HA, Hall FM, Steer ML. Preoperative localization of nonpalpable breast lesions demonstrated by mammography[J]. New Engl J Med,1976,295(5):259-260.
[6]
李二妮,周纯武,李静,等.乳腺密度的影响因素及其在乳腺疾病中的诊断价值[J].实用放射学杂志,2013,29(10):1570-1572.
[7]
Follacchio GA, Monteleone F, Meggiorini ML, et al. Radio-localization of non-palpable breast lesions under ultrasonographic guidance: current status and future perspectives[J]. Curr Radiopharm, 2017,10(3):178-183.
[8]
Layeequr RR, Crawford S, Larkin A, et al. Superiority of sonographic hematoma guided resection of mammogram only visible breast cancer: wire localization should be an exception-not the rule[J].Ann Surg Oncol,2007,14( 8):2228-2232.
[9]
Montrey JS, Levy JA, Brenner RJ. Wire fragments after needle localization[J]. AJR Am J Roentgenol,1996,167(5):1267-1269.
[10]
Janssen NN, Nijkamp J, Alderliesten T, et al. Radioactive seed localization in breast cancer treatment[J]. Br J Surg, 2016, 103(1):70-80.
[11]
Jiang Y, Lin N, Huang S, et al. Tracking nonpalpable breast cancer for breast-conserving surgery with carbon nanoparticles: implication in tumor location and lymph node dissection [J]. Medicine, 2015, 94(10):605-609.
[12]
陈冰,颜松龄,苏继钦.术前纳米炭标记对触诊阴性乳腺癌保乳手术的指导价值[J].临床合理用药杂志,2019, 12(34):23-25.
[13]
Francini S, Rathat G, Manna F, et al. Occult lesion localization by indocyanine green fluorescence for nonpalpable breast cancer [J]. Breast J, 2020, 26(5):1101-1103.
[14]
Monti S, Galimberti V, Trifiro G, et al. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology[J]. Ann Surg Oncol, 2007, 14(10):2928-2931.
[15]
Gennari R, Galimberti V, De CC, et al. Use of technetium-99m-labeled colloid albumin for preoperative and intraoperative localization of nonpalpable breast lesions[J].J Am Coll Surg, 2000,190(6):692-698.
[16]
Hawkins SC, Brown I, King P, et al. Time to go wireless? A 15-year single institution experience of radioisotope occult lesion localisation (ROLL) for impalpable breast lesions[J].Eur J Surg Oncol,2017,43(1):62-67.
[17]
Medina-Franco H, Abarca-Pérez L, García-Alvarez MN, et al. Radioguided occult lesion localization (ROLL) versus wire-guided lumpectomy for non-palpable breast lesions: a randomized prospective evaluation[J]. J Surg Oncol, 2008, 97(2):108-111.
[18]
Gray RJ, Giuliano R, Dauway EL, et al. Radioguidance for nonpalpable primary lesions and sentinel lymph node(s) [J]. Am J Surg,2001, 182(4):404-406.
[19]
Milligan R, Pieri A, Critchley A, et al. Radioactive seed localisation compared with wire-guided localisation of non-palpable breast carcinoma in breast conservation surgery-the first experience in the United Kingdom[J]. Br J Radiol, 2018,91(1081):20 170 268.
[20]
Gray RJ, Salud C, Nguyen K, et al. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization[J]. Ann Surg Oncol, 2001,8(9):711-715.
[21]
周军,汪瑞,沈俊,等.不可触及肿块的乳腺癌病灶定位与手术分析[J].实用癌症杂志,2014, 29(12):1658-1660.
[22]
Barentsz MW, van den Bosch MA, Veldhuis WB, et al. Radioactive seed localization for non-palpable breast cancer[J]. Br J Surg, 2013,100(5):582-588.
[23]
Alderliesten T, Loo CE, Pengel KE, et al.Radioactive seed localization of breast lesions: an adequate localization method without seed migration[J]. Breast J,2011, 17(6):594-601.
[24]
Fung F, Cornacchi SD, Reedijk M, et al. Breast cancer recurrence following radioguided seed localization and standard wire localization of nonpalpable invasive and in situ breast cancers: 5-year follow-up from a randomized controlled trial[J]. Am J Surg, 2017, 213(4):798-804.
[25]
Cox CE, Garcia-Henriquez N, Glancy MJ, et al. Pilot study of a new nonradioactive surgical guidance technology for locating nonpalpable breast lesions[J].Ann Surg Oncol,2016,23(6):1824-1830.
[26]
Patel SN, Mango VL, Jadeja P, et al. Reflector-guided breast tumor localization versus wire localization for lumpectomies: A comparison of surgical outcomes[J].Clin Imaging,2018,47:14-17.
[27]
Mango VL, Wynn RT, Feldman S, et al. Beyond wires and seeds: reflector-guided breast lesion localization and excision[J]. Radiology, 2017,284(2):365-371.
[28]
Zacharioudakis K, Down S, Bholah Z, et al. Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study[J]. Eur J Surg Oncol, 2019, 45(11):2016-2021.
[29]
Mcgugin C, Spivey T, Coopey S, et al. Radiofrequency identification tag localization is comparable to wire localization for non-palpable breast lesions[J]. Breast Cancer Res Treat,2019,177(3):735-739.
[1] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 刘敏, 唐恩溢, 刘喆, 葛苏蒙, 刘梅, 孙国文. 计算机导航技术在口腔颌面部微小异物取出手术中的应用[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 375-379.
[10] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[13] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[14] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[15] 王松雷, 张贻良, 孟浩, 宋威, 白林晨, 袁心, 张辉. 股骨前髁预截骨髓外定位技术在全膝关节置换术中的应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 811-819.
阅读次数
全文


摘要